CHI’s 2nd Annual Screening & Functional Analysis of 3D Models Conference Set for Nov. 18-19, 2014

NEEDHAM, Mass. - Aug. 19, 2014 - PRLog -- Cambridge Healthtech Institute (CHI) released the final agenda for its Second Annual Screening & Functional Analysis of 3D Models conference to be held on November 18-19, 2014, at the Hyatt Boston Harbor, Boston, MA.

This conference will explore the use of 3D models to profile compound action and predict toxicity and efficacy. The meeting will cover assay development using 3D cellular models, high-content analysis and imaging of 3D models, and applications of screening 3D models for compound profiling and target discovery/validation.

Speakers include:

Edna Cukierman, Ph.D., Associate Professor, Cancer Biology, Fox Chase Cancer Center

Jan E. Ehlert, Ph.D., Head, Cellular Drug Discovery, ProQinase GmbH

Mary C. Farach-Carson, Ph.D., Ralph and Dorothy Looney Professor, Biochemistry and Cell Biology; Scientific Director, BioScience Research Collaborative, Rice University

Shane R. Horman, Ph.D., Research Investigator, Advanced Assay Group, Genomics Institute of the Novartis Research Foundation

Aron Jaffe, Ph.D., Senior Investigator, Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research

Roger D. Kamm, Ph.D., Cecil and Ida Green Distinguished Professor, Biological and Mechanical Engineering, MIT

Jean-Louis Klein, Ph.D., Principal Scientist, Target and Pathway Validation, Platform Technology and Science, GlaxoSmithKline

Daniel V. LaBarbera, Ph.D., Assistant Professor, Drug Discovery and Medicinal Chemistry, The Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado

Claire Lugassy, M.D., Research Associate Professor, Pathology and Lab Medicine, UCLA School of Medicine; Member, Jonsson Comprehensive Cancer Center

David Nolte, Ph.D., Professor, Physics, Purdue University; President, Animated Dynamics, Inc.

Imran Rizvi, Ph.D., Instructor, Medicine and Dermatology, Harvard Medical School; Associate Bioengineer, Brigham and Women’s Hospital; Assistant, Biomedical Engineering, Wellman Center for Photomedicine, Massachusetts General Hospital

Scott S. Verbridge, Ph.D., Assistant Professor, School of Biomedical Engineering and Sciences, Virginia Tech – Wake Forest University

Alan H. Wells, M.D., D.M.Sc., Vice Chair and Thomas J. Gill III Professor, Pathology, University of Pittsburgh

Writers and editors are invited to attend. To request a press pass, contact Lisa Scimemi, lscimemi@healthtech.com.

Important Deadline Dates:
Early registration discount deadline: August 22, 2014
Poster abstract submission deadline: October 10, 2014

This conference is part of CHI’s Second Annual FAST: Functional Analysis & Screening Technologies Congress (Nov. 17-19).

Learn more and register at http://www.fastcongress.com/analysis-of-3d-models.

About Cambridge Healthtech Institute (chicorporate.com)

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation.